Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports.
about
Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severityMacrolide antibiotics and the risk of ventricular arrhythmia in older adults.Protective Effects of Carvedilol and Vitamin C against Azithromycin-Induced Cardiotoxicity in Rats via Decreasing ROS, IL1-β, and TNF-α Production and Inhibiting NF-κB and Caspase-3 ExpressionImmunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician.Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.Evaluation of azithromycin induced cardiotoxicity in rats.Does Azithromycin and Cetirizine Combination Given for Upper Respiratory Tract Infections has any Significant Effect on QTc?Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications.Re: Comparison of Azithromycin and Amoxicillin Before Dental Implant Placement: An Exploratory Study of Bioavailability and Resolution of Postoperative Inflammation.Guidelines for the management of paediatric cholera infection: a systematic review of the evidence.Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence.Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
P2860
Q33810580-D6424712-0333-4B03-B1EF-0ABAA08B7629Q36808701-73978ED8-1AD9-420F-A756-3BED57FE4008Q36914282-3D994236-CD6E-4E41-A154-F1D59701BD91Q39100345-12F888AD-CA73-467F-837A-293F02B3B08CQ40108685-D521566F-7CAF-4619-B512-BD05598779B6Q41043981-A7FCADF3-8B29-413D-83C8-AB5049F8BA6CQ47164069-1EADD4DC-5BB5-4E3B-A8F6-8F6D526218B9Q47292963-39A6CB10-38BB-4906-A68F-EB64DEFDC46BQ51454579-25C45D14-E37D-415E-A69A-18D70D441426Q55033466-D2CAB005-9286-4BCF-8696-13FDBB9C1ACEQ55453605-7D3E5AFC-3FF1-4410-A4A6-3A55C7C07AF3Q58567153-11031ABF-0ABB-4526-8622-0477123BD16A
P2860
Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Azithromycin, cardiovascular r ...... on the study of case reports.
@ast
Azithromycin, cardiovascular r ...... on the study of case reports.
@en
type
label
Azithromycin, cardiovascular r ...... on the study of case reports.
@ast
Azithromycin, cardiovascular r ...... on the study of case reports.
@en
prefLabel
Azithromycin, cardiovascular r ...... on the study of case reports.
@ast
Azithromycin, cardiovascular r ...... on the study of case reports.
@en
P2093
P2860
P356
P1476
Azithromycin, cardiovascular r ...... on the study of case reports.
@en
P2093
Adrian Baranchuk
Ericka L Breden Crouse
Jules C Hancox
Mehrul Hasnain
W Victor R Vieweg
P2860
P304
P356
10.1177/2049936113501816
P577
2013-10-01T00:00:00Z